comparison of cartitude-1 outcomes vs real world clinical practice observed in german registry
Published 3 years ago • 167 plays • Length 4:28Download video MP4
Download video MP3
Similar videos
-
2:08
comparison of the outcomes from cartitude-1 with a real-world external cohort
-
5:42
comparison of outcomes with cilta-cel in cartitude-1 vs rw soc for pts w/ triple-class exposed rrmm
-
2:15
comparison of patient-reported outcomes from cartitude-1 and locommotion
-
4:25
updated results from cartitude-1: phase 1b/2study of cilta-cel in pts with rr multiple myeloma
-
5:42
ciltacabtagene autoleucel in cartitude-1 vs standard of care in triple-class exposed mm pts
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
6:31
real-world multiple myeloma risk factors and outcomes by race/ethnicity in the united states
-
12:00
comparison of whole body mri and fdg pet/ct for detection of mm: results of the itimm trial
-
2:00
real-world outcomes of autosct for multiple myeloma in the first-line setting
-
1:05
real-world comparison of rvd vs d-rvd in newly diagnosed transplant-eligible multiple myeloma
-
1:05:39
imwg conference series: asco & eha 2023
-
3:37
updated data from cartitude-1 and cartitude-2 studies testing cilta-cel in r/r multiple myeloma
-
3:52
real-world data on outcomes of t(11;14) multiple myeloma
-
1:03:51
top myeloma research presented at asco & eha webinar 2023
-
3:01
clinical trials versus the real world
-
1:22
differentiating between amyloidosis and myeloma
-
7:23
cartitude-2: efficacy and safety of ciltacabtagene autoleucel in patients with progressive mm
-
2:45
myeloma: real-world data
-
6:54
ash23: cartitude-2 trial on ciltacabtagene autoleucel in multiple myeloma | jens hillengass, md, phd